US FDA grants accelerated approval to Day One Biopharma’s tovorafenib to treat relapsed or refractory BRAF-altered paediatric low-grade glioma: Brisbane, California Thursday, Ap ...
Lupin Digital Health’s Lyfe platform receives Class C Medical Device license from CDSCO: Our Bureau, Mumbai Thursday, April 25, 2024, 12:10 Hrs [IST] Lupin Digital Health, India ...
Novartis, MMV announce positive data from phase II/III CALINA study of Coartem to treat babies 5 kg with malaria: Basel Thursday, April 25, 2024, 12:00 Hrs [IST] Novartis and Medi ...
King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, Hinduja Hospital & Hinduja Foundation establish health partners academy: Our Bureau, Mumbai Thursday, April ...
EC grants label extension approval for Astellas’ Xtandi for use in additional recurrent early prostate cancer treatment setting: Tokyo Thursday, April 25, 2024, 11:00 Hrs [IST] ...
The WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving ...
The Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homoeopathy (Ayush) manufacturing industry in the country has registered around six times growth in seven years from the year 2014-15, ...
IIT Roorkee & UnivLabs tie up for commercialising technology related to ureteral stents: Our Bureau, New Delhi Thursday, April 25, 2024, 08:00 Hrs [IST] The Indian Institute of Te ...
IISc researchers design an antigen that boosts antibody production against cancer cells: Nandita Vijayasimha, Bengaluru Thursday, April 25, 2024, 08:00 Hrs [IST] Researchers at th ...
In response to requests from concerned stakeholders, the Directorate General of Trade Remedies (DGTR) has announced an extension for the filing of questionnaire responses in the ongoing anti-dumping ...
Par Pharma recalls seven lots of Treprostinil injection due to potential for silicone particulates in the product solution: Dublin Wednesday, April 24, 2024, 15:30 Hrs [IST] Endo ...